RecruitingNot ApplicableNCT07499765

Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis

Benefits of Formalized Care Support Program Following an Annoucement of Acute Leukemia Diagnosis


Sponsor

Centre Henri Becquerel

Enrollment

110 participants

Start Date

Mar 30, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine the impact on anxiety between patients with a period of care support following their announcement of an acute leukemia (AL) diagnosis and patients without this accompaniment.


Eligibility

Min Age: 26 YearsMax Age: 80 Years

Inclusion Criteria6

  • informed consent signed
  • medical confirmation of acute leukemia diagnosis
  • age equal of superior to 26 years and under 80 years
  • confirmed diagnosis not yet treated
  • hospitalization at Centre Henri Becquerel
  • member or beneficiary of a social security

Exclusion Criteria8

  • Patient unable to understand the study for any reason or to comply with the trial's requirements
  • Patient in relapse of acute leukemia
  • Patient diagnosed with acute myeloid leukemia 3
  • History of cancer within the 5 years preceding the year of study enrollment
  • Alcohol and drug abuse
  • Inclusion in another therapeutic trial that prevents further enrollment in a trial evaluating quality of life or psychological well-being
  • Diagnosed psychiatric illness
  • Patient under guardianship, curatorship, or legal protection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcare support program after diagnosis announcement

a dedicated time with a specialized nurse in announcement will be given tot the patient. The anxiety will also be evaluated


Locations(1)

Centre Henri Becquerel

Rouen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07499765


Related Trials